$HKPD
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares
XNAS
Why is HKPD down today? It is at $0.345 (-9.29%), and our scanner flagged it 8 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment HKPD spikes, and full due diligence on HKPD — key stats, earnings, dilution and insider activity. Free.
Get free $HKPD alerts the moment volume spikes
Our scanner flagged $HKPD 8 times in the last 30 days. Create a free account to track $HKPD, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.345
- Change today
- -9.29%
- Previous close
- $0.380
- 52-week range
- $0.318 – $2.58
- Market cap
- $8M
- Institutional own.
- 0.57%
- Total held
- 0.57%
- Tradeable float
- 23.4M 99% of shares · after 1% institutions
- Short interest
- 165K ▼ -21% vs prior · as of 2026-06-30
- Short % of float
- 0.7%
- Days to cover
- 2.3d
- Avg daily volume
- 910K
- Exchange
- XNAS
Get free HKPD + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $HKPD down today?
HKPD is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 8 unusual-volume and momentum alerts on HKPD today, peaking at 655.9x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Dilution watch
Active shelfActive shelf on file — the company can issue new shares on demand (valid ~3 years). If $HKPD runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$HKPD Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$HKPD Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
HKPD stock FAQ
Why is $HKPD down today?
HKPD is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 8 unusual-volume and momentum alerts on HKPD today, peaking at 655.9x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
What is the HKPD stock price today?
HKPD last traded at $0.345, down 9.29% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live HKPD alerts?
The HKPD Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged HKPD 8 times in the last 30 days.
What exchange is HKPD on?
HKPD (Cellyan Biotechnology Co., Ltd Class A Ordinary Shares) trades on XNAS, with a market cap of about $8M.
Is HKPD good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge HKPD for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.